The host immunological pathways are re-organized to get a clear picture. There are four acute immune responses: TH1/TH2/TH22/THαβ which are corresponding to four chronic immune responses: THfh/TH9/TH17/TH3. Then, the four branches of immune reactions can link to four types of hypersensitivities or allergies. Another inhibitory pathway Treg secreting TGF beta is the key player to shift the above acute immune responses to chronic immune responses for generating milder cytokines and other immune mediators to avoid severe destruction of organ during chronic and large scale of pathogen infection of tissue-organ. This 4x2+1 is the new diagram of host immunological pathways.
traditional TH1 immunity. The TH1 immunity is then focusing on intracellular bacteria and protozoa. TH1 immunity is driven by IL-12. The main effector cells of TH1 immunity are macrophages, CTLs, IFNg secreting CD4 T cells, and IgG3 producing B cells. The key transcription factors for TH1 immunity is STAT4 and STAT1. T-bet also plays a vital role in TH1 immunological pathway. TH1 immunity against self antigen is Type 4 Delayed type hypersensitivity such as tuberculin BCG reaction. TH2 immunity is driven by IL-4. The main effector cells of TH2 immunity are eosinophils, basophils, mast cells, IL-4/IL-5 secreting CD4 T cells, and IgG4/IgE producing B cells. The key transcription factor for TH2 immunity is STAT6. GATA3 also plays a vital role in TH2 immunological pathway. TH2 immunity against self antigen is Type1 IgE mediated allergy and hypersensitivity such as food allergy or urticaria.
THαβ is distinguished from the traditional TH1 immunity (2) . It was called Tr1 cell by some previous researchers. THαβ immunity is driven by IFNa/b or IL-10. (3) (4) (5) The main effector cells of THαβ immunity are NK cells, IL-10/IL-27 secreting CD4 T cells, CTLs, and IgG1 producing B cells. The key transcription factor for THαβ immunity is STAT1, STAT2, and STAT3. THαβ immunity against self antigen is Type 3 Antibody dependent cellular cytotoxic hypersensitivity such as Myasthenia Gravis.
TH22 is the host innate immunity against extracellular bacteria and fungi(6, 7). TH22 is driven by IL-6 or TNFa (8, 9) . The main effector cells for TH22 immunity are PMNs, IL-22 secreting CD4 T cells, complements, pentraxins, and IgM/IgG2 producing B cells.(10, 11) The key transcription factor for TH22 is STAT3(12). AP1 and CEBP are also important. TH22 against self antigen is Type 2 immune-complex and complement mediated hypersensitivity such as Arthus reaction.
Chronic immunological pathways
Treg is the host immune inhibitory mechanism(13). It is driven by IL-2 and TGF beta.
The main effector cells for Treg are TGFb producing CD4 T cell and IgA producing B cell. The key transcription factor for Treg pathway is STAT5. The combination of Treg and the above four immunological pathways is important to shift acute immunity to chronic immunity. During the initial infection, acute fierce cytokines can rapidly kill pathogens as well as infected cells or tissues. However, if the pathogen infects a lot of cells in a tissue such as liver, to kill the infected cells will total destroyed the organ. peer-reviewed) is the author/funder. All rights reserved. No reuse allowed without permission.
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In the chronic situation, TGF beta cooperates with either IL-10(TH3), IL-6(TH17), IL-4(TH9) or IL-21(THfh) will cause B cell isotype switch to IgA.(14-17) Thus, regulatory T cells combining TH1/TH2/TH22/THαβ will make CD4 T cells with less fierce cytokines.
Then, THfh/TH9/TH17/TH3 immunological pathways will be generated in the chronic infection or hypersensitivity. by IL-21 producing T cells (28, 29) . TGF beta is found to differentiate the IL-21 producing helper T cells (30) (31) (32) . IL-21 production is also related to STAT4 and STAT1 activation. peer-reviewed) is the author/funder. All rights reserved. No reuse allowed without permission.
